Skip to main content

stock

LPCN · Lipocine Inc.

What Lipocine Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live LPCN price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on LPCN.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
8,244,253 as of 2026-08-03 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
-800.8%
Net
-755.3%

Returns

ROE
-54.5%
ROA
-49.7%

Health

Current ratio
11.5x
Debt/equity
—

Deep value

NCAV
$21.67M
NCAV per share
$2.63
Price/NCAV
Locked
NNWC
$2.91M
NNWC per share
$0.35
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30$190,099—Gross profit: unreported by this company.-$2.84M-$2.62M
10-Q filed 2026-08-04
2026-03-31$119,397—Gross profit: unreported by this company.-$3.85M-$3.67M
10-Q filed 2026-05-07
2025-12-31$1.15M—Gross profit: unreported by this company.-$2.52M-$2.37M
DEF 14A filed 2026-04-21
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$114,574—Gross profit: unreported by this company.-$3.36M-$3.19M
10-Q filed 2025-11-06
2025-06-30$622,849—Gross profit: unreported by this company.-$2.40M-$2.21M
10-Q filed 2026-08-04
2025-03-31$93,864—Gross profit: unreported by this company.-$2.09M-$1.86M
10-Q filed 2026-05-07
2024-12-31——Gross profit: unreported by this company.$1.55M$1.78M
DEF 14A filed 2026-04-21
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30——Gross profit: unreported by this company.-$2.63M-$2.22M
10-Q filed 2025-11-06
Assets
$23.84M
Equity
$21.77M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$1.98M-$10.37M-$9.63M—
2024-12-31$11.20M-$1.16M$10,000-$1.31M
2023-12-31-$2.85M-$17.93M-$16.35M-$11.88M
2022-12-31$500,000-$12.12M-$10.76M-$12.10M
2021-12-31$16.14M$3.15M-$634,399-$4.42M
2020-12-31$0-$18.00M-$20.96M—
2019-12-31$164,990-$12.90M-$13.01M—
2018-12-31$428,031-$11.33M-$11.66M-$12.08M
2017-12-31$0-$21.22M-$20.98M-$16.70M
2016-12-31$0-$19.19M-$18.97M-$18.34M

Company filings

1 offering filing in 12 months

events

  • Other event

    Other event
    Sep 168-K
  • Other event

    Other event
    Sep 148-K
  • Other event

    Other event
    Sep 118-K
  • Other event

    Other event
    Sep 108-K
  • Executive or director change

    Executive or director change
    Aug 218-K/A
  • Results

    Results
    Aug 48-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Higuchi John W.

    Director

    Buy$55,043

    Oct 1, 8:28 PM ET

  • Higuchi John W.

    Director

    Buy$27,132

    Sep 30, 8:38 PM ET

All insider trades for LPCN

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named LPCN, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about LPCN.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about LPCN.

nakagai

Signals on LPCN come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the LPCN board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Lipocine Inc. (LPCN): SEC filings, financials and insider trades · Nakagai